Use of Visual Electrophysiology to Monitor Retinal and Optic Nerve Toxicity

Biomolecules. 2022 Sep 29;12(10):1390. doi: 10.3390/biom12101390.

Abstract

It is important for clinicians to consider exposure to toxic substances and nutritional deficiencies when diagnosing and managing cases of vision loss. In these cases, physiologic damage can alter the function of key components of the visual pathway before morphologic changes can be detected by traditional imaging methods. Electrophysiologic tests can aid in the early detection of such functional changes to visual pathway components, including the retina or optic nerve. This review provides an overview of various electrophysiologic techniques, including multifocal electroretinogram (mfERG), full-field ERG (ffERG), electrooculogram (EOG), pattern electroretinogram (PERG), and visual evoked potential (VEP) in monitoring the retinal and optic nerve toxicities of alcohol, amiodarone, cefuroxime, cisplatin, deferoxamine, digoxin, ethambutol, hydroxychloroquine, isotretinoin, ocular siderosis, pentosane, PDE5 inhibitors, phenothiazines (chlorpromazine and thioridazine), quinine, tamoxifen, topiramate, vigabatrin, and vitamin A deficiency.

Keywords: drug; electrooculogram; electrophysiology; electroretinogram; eye; functional exam; optic nerve; retina; toxicity; visual evoked potential.

Publication types

  • Review

MeSH terms

  • Amiodarone*
  • Cefuroxime
  • Chlorpromazine
  • Cisplatin
  • Deferoxamine
  • Digoxin
  • Electrophysiology
  • Ethambutol
  • Evoked Potentials, Visual*
  • Humans
  • Hydroxychloroquine
  • Isotretinoin
  • Optic Nerve
  • Phosphodiesterase 5 Inhibitors
  • Quinine
  • Retina
  • Tamoxifen
  • Thioridazine
  • Topiramate
  • Vigabatrin

Substances

  • Ethambutol
  • Vigabatrin
  • Hydroxychloroquine
  • Thioridazine
  • Quinine
  • Cefuroxime
  • Isotretinoin
  • Topiramate
  • Phosphodiesterase 5 Inhibitors
  • Chlorpromazine
  • Cisplatin
  • Deferoxamine
  • Digoxin
  • Tamoxifen
  • Amiodarone

Grants and funding

This research received no external funding.